We calculated the correlations between the expressions levels of the DKK3, CTNNB1, FSTL1, and CSNK1A1 genes and eight immune cell fractions in grade II or III glioma and GBM (Fig. 2C and D). This evidence concerns the gene CTNNB1 and central nervous system cancer.